Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Recursion, Takeda enter rare disease discovery partnership

October 10, 2017 11:33 PM UTC

Recursion Pharmaceuticals Inc. (Salt Lake City, Utah) and Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) will collaborate to discover preclinical rare disease candidates for Takeda's TAK-celerator pipeline.

Recursion will receive an undisclosed upfront payment and is eligible for more than $90 million in milestones, plus royalties. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article